Abstract
A levofloxacin-based triple therapy and a rifabutin-based regimen are advised as second-line and rescue therapies in the current Italian guidelines for H. pylori eradication. However, no data are available for the efficacy of these treatments in clinical practice.
| Lingua originale | English |
|---|---|
| pagine (da-a) | 131-134 |
| Numero di pagine | 4 |
| Rivista | Journal of Gastrointestinal and Liver Diseases |
| Volume | 19 |
| Stato di pubblicazione | Pubblicato - 2010 |
| Pubblicato esternamente | Sì |
Keywords
- Aged
- Amoxicillin
- Anti-Bacterial Agents
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Helicobacter Infections
- Helicobacter pylori
- Humans
- Italy
- Male
- Medication Adherence
- Middle Aged
- Ofloxacin
- Omeprazole
- Practice Guidelines as Topic
- Proton Pump Inhibitors
- Rifabutin
- Time Factors
- Treatment Failure